Company intelligence
Envol Biomedical
Translating Molecules into Therapeutics
Biotechnology Research
New York City, US
49 employees
Founded 2019
1 public signals
About Envol Biomedical
General Information: • Non-human primate preclinical research • Largest population available in the continental U.S. • On time delivery of study samples and study reports. • GLP, AAALAC accredited, USDA and OLAW compliant. Services and Capabilities: • Pharmacokinetics and ADME • Pharmacodynamics and biomarkers • GLP Toxicology
Verified activity
Signals from Envol Biomedical
1 published signal